Pages that link to "Q87135143"
Jump to navigation
Jump to search
The following pages link to The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes (Q87135143):
Displaying 18 items.
- Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice (Q33644666) (← links)
- Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset (Q35837580) (← links)
- Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3 (Q37532382) (← links)
- Th17 cells in cancer: the ultimate identity crisis. (Q38225542) (← links)
- Antidiabetic therapy in post kidney transplantation diabetes mellitus. (Q38340187) (← links)
- Combination immunotherapies for type 1 diabetes mellitus (Q38358009) (← links)
- Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins (Q38670397) (← links)
- Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else? (Q52562630) (← links)
- Herpes Zoster and Diabetes Mellitus: A Review. (Q52665372) (← links)
- Dipeptidyl peptidase-4 inhibitors have adverse effects for the proliferation of human T cells (Q57125138) (← links)
- Dipeptidyl dipeptidase-4 inhibitor recovered ischemia through an increase in vasculogenic endothelial progenitor cells and regeneration-associated cells in diet-induced obese mice (Q64077617) (← links)
- Incretin-based therapies for patients with type 1 diabetes: a meta-analysis (Q64253654) (← links)
- Acquired Hemophilia A Associated with Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Single-Center Case Series in Japan. (Q64890811) (← links)
- Altered T-cell subsets and transcription factors in latent autoimmune diabetes in adults taking sitagliptin, a dipeptidyl peptidase-4 inhibitor: A 1-year open-label randomized controlled trial (Q89041116) (← links)
- Systems pharmacology-based approach for dissecting the mechanisms of pyrazine components in Maotai liquor (Q90068483) (← links)
- Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes (Q90324457) (← links)
- DPP8 is a novel therapeutic target for multiple myeloma (Q91620510) (← links)
- Past, present and future of latent autoimmune diabetes in adults (Q91984134) (← links)